(Q28573536)

English

A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells

scientific journal article

In more languages

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells (English)

1 reference

PubMed publication ID

31 January 2017

1 reference

based on heuristic

inferred from title

prostate adenocarcinoma

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Miao Ding

1

1 reference

PubMed publication ID

31 January 2017

Biaoyang Lin

2

1 reference

PubMed publication ID

31 January 2017

Tao Li

3

1 reference

PubMed publication ID

31 January 2017

Yuanyuan Liu

4

1 reference

PubMed publication ID

31 January 2017

Yuhua Li

5

1 reference

PubMed publication ID

31 January 2017

Xiaoyu Zhou

6

1 reference

PubMed publication ID

31 January 2017

Maohua Miao

7

1 reference

PubMed publication ID

31 January 2017

Jinfa Gu

8

1 reference

PubMed publication ID

31 January 2017

Hongjie Pan

9

1 reference

PubMed publication ID

31 January 2017

Fen Yang

10

1 reference

PubMed publication ID

31 January 2017

Tianqi Li

11

1 reference

PubMed publication ID

31 January 2017

Xin Yuan Liu

12

1 reference

PubMed publication ID

31 January 2017

Runsheng Li

13

1 reference

PubMed publication ID

31 January 2017

language of work or name

0 references

publication date

10 April 2015

1 reference

PubMed publication ID

31 January 2017

1 reference

PubMed publication ID

31 January 2017

6

1 reference

PubMed publication ID

31 January 2017

10

1 reference

PubMed publication ID

31 January 2017

7686–7700

1 reference

PubMed publication ID

31 January 2017

Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

19 March 2017

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

19 March 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

19 March 2017

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

19 March 2017

A microRNA component of the p53 tumour suppressor network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

19 March 2017

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

19 March 2017

Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Lineage relationship of prostate cancer cell types based on gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

PC3 is a cell line characteristic of prostatic small cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Molecular genetics of prostate cancer: new prospects for old challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Differential regulation of microRNA stability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Microrna profiling analysis of differences between the melanoma of young adults and older adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Neuroendocrine differentiation in prostate cancer: from lab to bedside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Unusual subtypes of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Molecular characterization of human prostate carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

A new human prostate carcinoma cell line, 22Rv1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

29 September 2017

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

3 June 2018

miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

27 November 2018

NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

27 November 2018

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

27 November 2018

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

27 November 2018

Androgen receptor outwits prostate cancer drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

27 November 2018

Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480709

27 November 2018

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25797256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25797256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/25797256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25797256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/25797256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25797256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25797256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.3480

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28573536&oldid=1970497511"